Survival analysis comparing patients with high CXCR2 expression (n = 114) to patients with lower CXCR2 expression (n = 107) indicates that CXCR2 expression correlates with decreased overall survival of melanoma patients (p = 0.035, Fig. 1C). The gene discussed is CXCR2; the disease is melanoma.